#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalopathy neonatal Neurodevelopmental disorder Pancreatic neuroendocrine tumour Pericarditis Arteriovenous malformation Malignant central nervous system neoplasm Postprandial hypoglycaemia Methylmalonic acidaemia Ovarian cancer Hereditary neuropathic amyloidosis Thermal burn Leiomyosarcoma metastatic Oesophageal squamous cell carcinoma stage III Primary adrenal insufficiency Fabry's disease More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome – Treatment Glycogen storage disease type I – Trials in Disease Haemophilia A without inhibitors Mantle cell lymphoma stage II – Life with Disease Hepatic angiosarcoma – Basic Information Primary immunodeficiency syndrome – Trials in Disease Retinitis pigmentosa – Trials in Disease Mucopolysaccharidosis II Ehlers-Danlos syndrome – Trials in Disease Ewing’s sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZIGAKIBART Galcanezumab Tisotumab Vedotin Op-1250 Dapirolizumab Pegol Belinostat SAROGLITAZAR HEMIMAGNESIUM Mk-2060 MALIC ACID Fluorouracil Sodium Sparsentan (-)-PHENSERINE TARTRATE Cefepime Hydrochloride BRENSOCATIB Flucloxacillin Fludarabine Carfilzomib Duvakitug Df6002 VG801-2 More therapies…

    Learn about Your Condition

    Renal disorder Hairy cell leukaemia Normal pressure hydrocephalus Pneumonia bacterial Glomerulonephritis chronic Neuromyopathy Metastases to lymph nodes Malabsorption Fibrosarcoma metastatic Thyroid cancer Bronchostenosis Cardiac failure Cardiogenic shock Non-Hodgkin's lymphoma Inclusion body myositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Spitalul Clinic Judetean De Urgenta Pius Brinzeu

Spitalul Clinic Judetean De Urgenta Pius Brinzeu

Bkmbvcrrkv Llegw Rpgaglnz 1wiz Txfcuvefor 3fplzsq Rkmvxnr

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

    Recruiting

    3 1 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Efficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes

    Recruiting

    2 1 1
    Investigated Drugs:
    • Semaglutide
    Germany Hungary Poland Romania Slovakia Spain

  • BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

    Recruiting

    2 1
    Investigated Diseases:
    • Renal disorder
    Investigated Drugs:
    • [4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
    Belgium Croatia Denmark Estonia France Germany +10

  • RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

    Recruiting

    3 1
    Czechia France Germany Hungary Italy Poland +2

  • A study on the effectiveness of cagrilintide and semaglutide for weight management in children and adolescents with obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Croatia Denmark Hungary +8

  • Orforglipron for stress urinary incontinence in women with obesity or overweight

    Recruiting

    3 1
    Czechia Poland Romania

  • Long-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn’s disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4

  • Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transitional cell cancer of the renal pelvis and ureter
    Investigated Drugs:
    • Mitomycin
    Bulgaria Hungary Latvia Poland Romania Spain

  • Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

    Recruiting

    3 1
    Investigated Drugs:
    • Dnth103
    Belgium Bulgaria Croatia Denmark France Germany +6

  • Study on the Effectiveness of EscharEx and Amnion/Chorion Membrane Allograft for Patients with Venous Leg Ulcers

    Recruiting

    3 1
    Investigated Diseases:
    • Skin ulcer
    Austria Germany Italy Poland Romania Spain
1 2 3 … 5
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!